UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Finding low-cost retirement plans can significantly boost your savings. Discover options that won't break the bank!
23,355 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
The White House confirms a policy review of a temporary Jones Act waiver as oil nears $100 a barrel and fuel costs ri...
BitMine announces a sizable addition to its Ethereum stash, buying about 61,000 ETH and boosting holdings to about 4....
Former BitMEX chief Arthur Hayes reportedly acquired a tranche of ETHFI ahead of Upbit's listing, sparking a price sp...
Insiders are loading up Arbor Realty Trust while bears keep a large short position. The clash over who’s right Arbor ...
Palantir connects data, software, and decision-making in a way that could reshape enterprise AI. This guide outlines ...
An anonymous investor continues to buy the VanEck Uranium and Nuclear ETF every month, betting on nuclear power's lon...
SoundHound AI's 2026 earnings journey sheds light on how voice AI monetizes across devices. This guide breaks down th...
Disney is testing a bold move: a unified app that ties together its streaming, parks, and products. This article brea...
Meta Platforms posts stronger growth in Q1 2026, lifting revenue and margins while the stock trades at a meaningful d...
Microsoft posts solid Q3 results, showing AI and cloud momentum that investors say could unlock value in Big Tech. Th...
European leaders weigh price caps on essentials to curb inflation, a move that has CEOs warning of market distortions...